Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Label Open Date on Latanoprost Eye Drops

Texas City, Texas Survey Completed on 04-25-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that all drugs and biologicals, specifically Latanoprost eye drops, were labeled with the date they were opened on at least one medication cart. During observation, it was found that the Latanoprost 0.005% eye drops for a female resident with a diagnosis of open-angle glaucoma and diabetes were not labeled with an open date. The medication administration record and care plan confirmed the ongoing use of these eye drops for the resident. Multiple staff interviews, including with medication aides, the DON, ADON, and the facility pharmacist, confirmed that eye drops should be dated when opened to ensure proper disposal within the recommended timeframe. Staff and pharmacy audits of medication carts were reported to occur weekly and monthly, respectively, but the lack of an open date on the Latanoprost eye drops was not identified or corrected prior to the survey. The facility's policy required medications to be stored properly and outdated or deteriorated medications to be removed immediately, but this policy was not followed in this instance, resulting in the deficiency.

An unhandled error has occurred. Reload 🗙